Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Strategy
Strategic Acquisitions: Their Mistake Could Be Your Next Opportunity
During this interest rate and inflation cycle, make your M&A shopping list early but be selective.
By
Kal Vadasz
| June 27, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Sean Brandle
Human Capital & Careers
Walgreen, Express Scripts End War
The pharmacy chain blinks first in the parties' epic pricing struggle — perhaps setting the stage for corporate cost savings on drug benefits.
By
David McCann
| July 19, 2012
Read More
Human Capital & Careers
Companies May Win This Drug War
The conflict between Express Scripts and Walgreen just might lead to lower drug-benefit costs for companies.
By
David McCann
| March 1, 2012
Read More
Human Capital & Careers
Walgreen-Express Scripts War Could Cut Drug Costs
The pricing donnybrook between the giant chain and the big pharmacy benefits manager could give plan sponsors more market clout.
By
David McCann
| January 18, 2012
Read More
